Holly Wobma
Holly completed an MD-PhD at Columbia University in New York during which she conducted graduate training in the lab of Gordana Vunjak-Novakovic and helped co-found a cell therapy company called Immplacate. She will soon be starting (June 2019) as a pediatric resident at the Boston Combined Residency Program and is interested in developing and translating cell and gene therapies for pediatric disease.
Posts by: Holly
Kidney engineering – a biological filter for drug development
> You need only look at an old air conditioner filter to gain an enormous appreciation for our kidneys. Every day, our kidneys filter just under 200L of fluid, filled with all kinds of gnarly toxins that we’d rather not know about. Most of the time, they operate glitch free. But sometimes, the toxins they […]
Unraveling the mysteries of blood: Gene that regulates self-renewal discovered
Are we beginning to understand the complex conversations that control blood stem cell fate? Researchers in Toronto have found how one gene, GATA-3, helps prolong self-renewal properties. > They say working on the trauma unit isn’t for the faint of heart. But I think this also applies to being an immunologist. Because not only do […]
True Blood: An enterprise in engineering
True synthetic blood is coming, but it won’t be packaged like this. We’ve all heard the idiom “it’s in my blood”. For me, this applies to hockey and rock climbing. And a quick survey of my class suggests that everything from Southern BBQ sauce and ice cream to tea and motorcycle fluid (yikes!) runs […]
iPS cell banking: How to almost, but not quite, have patient matched stem cell therapies
> For anyone following the celebrity gossip of the stem cell field, you’ve probably come across one of our rising stars, the induced pluripotent stem cell (iPSC). Award winning and deemed to have loads of potential, each one of us can produce this type of cell. The buzz around iPSCs revolves around their ability to […]